Origene | GenomeWeb

Origene

OriGene Technologies said this week that it has acquired Foster City, Calif.-based immunoassay firm BioCheck.

NEW YORK (GenomeWeb News) – OriGene Technologies announced that it has received a contract from the National Cancer Institute to develop high affinity anti-peptide antibodies for SISCAPA assays.

NEW YORK (GenomeWeb News) – OriGene Technologies and SDIX today announced a definitive agreement for OriGene to buy the Life Science assets of SDIX for $16 million.

NEW YORK (GenomeWeb News) – OriGene Technologies today announced the completion of its $21.3 million Series C financing round.
Qiming Venture Partners and Kleiner Perkins Caufield Byers China led the round, while existing investor IDG-Accel also participated, OriGene said.

Canada's Centre of Excellence for the Prevention of Organ Failure – also called the PROOF Centre – has partnered with Origene Technologies on blood-based protein assays for monitoring heart and kidney transplantation.

Proteome Sciences this week introduced its SysQuant Assay, a multiplexed mass spec-based assay for quantification of phosphoproteins.

New Product Watch

Premium

Affymetrix this week launched its Human Transcriptome Array.

New Product Watch

Premium

BlueGnome's CytoChip SNP 4x180K and CytoChip Cancer SNP 4x180K Microarrays, Origene Technologies' TrueMab Antibody Portfolio

New Products

Premium

Origene

New Products

Premium

Agilent, Thermo Fisher Scientific, Waters, NextGen Sciences, Protea Biosciences, Origene

Pages

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.